Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

PubWeight™: 2.76‹?› | Rank: Top 1%

🔗 View Article (PMID 28122885)

Published in Circulation on January 25, 2017

Authors

Emelia J Benjamin, Michael J Blaha, Stephanie E Chiuve, Mary Cushman, Sandeep R Das, Rajat Deo, Sarah D de Ferranti, James Floyd, Myriam Fornage, Cathleen Gillespie, Carmen R Isasi, Monik C Jiménez, Lori Chaffin Jordan, Suzanne E Judd, Daniel Lackland, Judith H Lichtman, Lynda Lisabeth, Simin Liu, Chris T Longenecker, Rachel H Mackey, Kunihiro Matsushita, Dariush Mozaffarian, Michael E Mussolino, Khurram Nasir, Robert W Neumar, Latha Palaniappan, Dilip K Pandey, Ravi R Thiagarajan, Mathew J Reeves, Matthew Ritchey, Carlos J Rodriguez, Gregory A Roth, Wayne D Rosamond, Comilla Sasson, Amytis Towfighi, Connie W Tsao, Melanie B Turner, Salim S Virani, Jenifer H Voeks, Joshua Z Willey, John T Wilkins, Jason Hy Wu, Heather M Alger, Sally S Wong, Paul Muntner, American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Associated clinical trials:

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic™ (PREEMPT-HF) | NCT03579641

Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) | NCT03615469

Wrist-based Blood Pressure Monitoring Study | NCT03661112

Predictors for Prehospital Delay in Stroke Treatment | NCT03759691

Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE) | NCT03862651

IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest (IMICA) | NCT03863015

Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke (Strokeback01) | NCT03865225

Automated Diagnosis of Stroke in Computed Tomography With the Use of Artificial Intelligence | NCT03874702

RiSE to Prevent Cardiovascular Disease in African Americans | NCT03878290

High-intensity Interval Training After Stroke | NCT03942588

Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes | NCT03968809

Feasibility of a Stroke Specific Self-management Program | NCT03993574

Addressing Hypertension Care in Africa (ADHINCRA) | NCT04010344

Effect of Using Endotracheal Tube Introducer for Intubation During Mechanical Chest Compressions in a Manikin | NCT04116333

Articles citing this

Multistate 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project. J Am Heart Assoc (2017) 0.86

Update on Neurocritical Care of Stroke. Curr Cardiol Rep (2017) 0.75

Prevalence and Clinical Characteristics of Dyslipidemia in Koreans. Endocrinol Metab (Seoul) (2017) 0.75

No Racial Difference in Rehabilitation Therapy Across All Post-Acute Care Settings in the Year Following a Stroke. Stroke (2017) 0.75

Recent Trends in Clot Retrieval Devices: A Review. Cardiol Ther (2017) 0.75

Beta Blocker Administration During Emergency Department Evaluation for Acute Coronary Syndrome Is Associated With Lower Posttraumatic Stress Symptoms 1-Month Later. J Trauma Stress (2017) 0.75

Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014). Cardiovasc Diabetol (2017) 0.75

Ablation as targeted perturbation to rewire communication network of persistent atrial fibrillation. PLoS One (2017) 0.75

Emergency Neurological Life Support: Acute Ischemic Stroke. Neurocrit Care (2017) 0.75

Association of antiplatelet therapy with patient outcomes after out-of-hospital cardiac arrest. Resuscitation (2017) 0.75

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation. Front Pharmacol (2017) 0.75

Skeletal muscle alterations in HFrEF vs. HFpEF. Curr Heart Fail Rep (2017) 0.75

Renin Angiotensin Aldosterone Inhibition in the Treatment of Cardiovascular Disease. Pharmacol Res (2017) 0.75

Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med (2017) 0.75

Impact of Site Selection and Study Conduct on Outcomes in Global Clinical Trials. Curr Heart Fail Rep (2017) 0.75

Heart Failure Is Not Going Anywhere: Good News, Bad News. J Card Fail (2017) 0.75

Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial. J Med Internet Res (2017) 0.75

The circular RNA MICRA for risk stratification after myocardial infarction. Int J Cardiol Heart Vasc (2017) 0.75

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care (2017) 0.75

Visit-to-Visit Blood Pressure Variability in Young Adulthood and Hippocampal Volume and Integrity at Middle Age: The CARDIA Study (Coronary Artery Risk Development in Young Adults). Hypertension (2017) 0.75

Transcriptome Profiling in Systems Vascular Medicine. Front Pharmacol (2017) 0.75

Clinical Application of Genetic Testing in Heart Failure. Curr Heart Fail Rep (2017) 0.75

Association of the single nucleotide polymorphism in chromosome 9p21 and chromosome 9q33 with coronary artery disease in Chinese population. BMC Cardiovasc Disord (2017) 0.75

Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association. J Am Heart Assoc (2017) 0.75

The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates. Curr Atheroscler Rep (2017) 0.75

The relationship between cardiac endothelium and fibroblasts: it's complicated. J Clin Invest (2017) 0.75

Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts. Front Pharmacol (2017) 0.75

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation. Front Pharmacol (2017) 0.75

TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. PLoS One (2017) 0.75

Hypertension in Obesity and the Impact of Weight Loss. Curr Cardiol Rep (2017) 0.75

Dietary Nitrate Supplementation Opposes the Elevated Diaphragm Blood Flow in Chronic Heart Failure during Submaximal Exercise. Respir Physiol Neurobiol (2017) 0.75

Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca(2+)-Calcineurin-Mediated Drp1 Signaling Pathways. Int J Mol Sci (2017) 0.75

Health Insurance Expansion and Incidence of Out-of-Hospital Cardiac Arrest: A Pilot Study in a US Metropolitan Community. J Am Heart Assoc (2017) 0.75

Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest (2017) 0.75

The presence of obesity paradox in Greek patients with chronic heart failure. Pragmat Obs Res (2017) 0.75

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure. Curr Heart Fail Rep (2017) 0.75

Heart Failure: A Class Review of Pharmacotherapy. P T (2017) 0.75

Shared heart failure knowledge and self-care outcomes in patient-caregiver dyads. Heart Lung (2017) 0.75

Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor. Trends Endocrinol Metab (2017) 0.75

Improving Medication Adherence in Coronary Heart Disease. Curr Cardiol Rep (2017) 0.75

Cardiovascular risk factors among women with self-reported infertility. Fertil Res Pract (2017) 0.75

REV-ERBα ameliorates heart failure through transcription repression. JCI Insight (2017) 0.75

Cytochrome P450 Eicosanoids in Cerebrovascular Function and Disease. Pharmacol Ther (2017) 0.75

Cardiac progenitor cells: old is not always gold. J Physiol (2017) 0.75

Inflammatory potential of diet and risk of cardiovascular disease or mortality: A meta-analysis. Sci Rep (2017) 0.75

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain. Receptors Clin Investig (2017) 0.75

Red Blood Cell Eicosapentaenoic Acid Inversely Relates to MRI-Assessed Carotid Plaque Lipid Core Burden in Elders at High Cardiovascular Risk. Nutrients (2017) 0.75

Racial Disparities in Risks of Stroke. N Engl J Med (2017) 0.75

Transcranial Doppler and Microemboli Detection: Relationships to Symptomatic Status and Histopathology Findings. Ultrasound Med Biol (2017) 0.75

Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke. FASEB J (2017) 0.75

Hemorrhagic versus ischemic stroke: Who can best benefit from blended conventional physiotherapy with robotic-assisted gait therapy? PLoS One (2017) 0.75

Nutrition Education for Cardiologists: The Time Has Come. Curr Cardiol Rep (2017) 0.75

Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis. Am J Transl Res (2017) 0.75

Survival From Out-of-Hospital Cardiac Arrest: Are We Beginning to See Progress? J Am Heart Assoc (2017) 0.75

What Should We Learn From the Recent Decline of Basic Cardiovascular Science in Japan? Circ Res (2017) 0.75

Transplantation of Isl1(+) cardiac progenitor cells in small intestinal submucosa improves infarcted heart function. Stem Cell Res Ther (2017) 0.75

Changing concepts in hypertension management. J Hum Hypertens (2017) 0.75

Effect of Low-Dose Alcohol Consumption on Inflammation Following Transient Focal Cerebral Ischemia in Rats. Sci Rep (2017) 0.75

3D Bioprinting and In Vitro Cardiovascular Tissue Modeling. Bioengineering (Basel) (2017) 0.75

Psychological Stress, Inflammation, and Coronary Heart Disease. Curr Cardiol Rep (2017) 0.75

Articles cited by this

(truncated to the top 100)

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (2004) 39.54

Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc (2008) 38.10

Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA (2014) 34.12

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 26.76

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet (2011) 24.73

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA (2001) 24.12

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics (2007) 23.88

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23

Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17

Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49

Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet (2011) 19.21

A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA (2013) 18.86

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98

Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30

The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 14.88

Smoking and mental illness: A population-based prevalence study. JAMA (2000) 14.17

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation (2006) 13.21

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet (1999) 13.19

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70

Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 12.45

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06

Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78

Economic costs of diabetes in the U.S. in 2012. Diabetes Care (2013) 11.74

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 11.64

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63

Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care (2008) 10.90

Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75

Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med (2011) 10.33

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.02

Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56

Statins: new American guidelines for prevention of cardiovascular disease. Lancet (2013) 9.56

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40

Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet (2011) 9.37

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA (2012) 9.37

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation (2008) 8.94

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation (2009) 8.93

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72

Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med (2005) 13.14

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79

Obesity and the risk of heart failure. N Engl J Med (2002) 12.58

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med (2003) 10.84

Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43